Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Oncology Nursing Forum|August 31, 2011
An Internet intervention for management of uncertainty during active surveillance for prostate cancerMeredith Wallace Kazer, Donald E Bailey, Martin Sanda, et al.
European Urology Focus|July 8, 2022
Guidelines on Germline Testing for Urologic Tumor SyndromesPatrick T Gomella, James Ryan Mark, Veda N Giri, et al.
Cancer Letters|January 18, 2011
Genome-wide methylation analysis identifies involvement of TNF-α mediated cancer pathways in prostate cancerSun Jung Kim, William Kevin Kelly, Alan Fu, et al.
Cancer|November 8, 2008
Multicenter phase 2 study of neoadjuvant paclitaxel, estramustine phosphate, and carboplatin plus androgen deprivation before radiation therapy in patients with unfavorable-risk localized prostate cancer: results of Cancer and Leukemia Group B 99811William Kevin Kelly, Susan Halabi, Aymen Elfiky, et al.
Cancer Chemotherapy and Pharmacology|April 23, 2016
Phase I study of safety and tolerability of sunitinib in combination with sirolimus in patients with refractory solid malignancies and determination of VEGF (VEGF-A) and soluble VEGF-R2 (sVEGFR2) in plasmaJia Li, Harriet Kluger, Lesley Devine, et al.
Urology|December 29, 2020
Preserving Well-being in Patients With Advanced and Late Prostate CancerNathan R Handley, Felix Y Feng, Theresa A Guise, et al.
Therapeutic Advances in Urology|June 26, 2023
Bispecific PSMA antibodies and CAR-T in metastatic castration-resistant prostate cancerKevin K Zarrabi, Vivek Narayan, Patrick J Mille, et al.
Urology|July 13, 2004
Five-year outcomes after neoadjuvant chemotherapy and conformal radiotherapy in patients with high-risk localized prostate cancerCharles J Ryan, Michael J Zelefsky, Glenn Heller, et al.
Nature Reviews. Urology|November 13, 2019
Radium-223 mechanism of action: implications for use in treatment combinationsMichael J Morris, Eva Corey, Theresa A Guise, et al.
Cancers|August 12, 2022
Outcomes Following Abiraterone versus Enzalutamide for Prostate Cancer: A Scoping ReviewYash B Shah, Amy L Shaver, Jacob Beiriger, et al.
Pageof 5